
Kwanan nan Wuhan Oryza Biotechnology Co., Ltd. (Oryza Biotechnology) ya buga abubuwan da ake so, sharuɗɗa da sanarwa na farko a gidan yanar gizon hukuma na kasuwar hada-hadar hannayen jari ta Shanghai, yana bayyana yadda lamarin ya fara. Wannan yana nufin cewa Oryza Biotechnology shine kamfani na farko da ya fara saduwa kuma ya sami amincewa don yin rajista, kuma kamfani na farko da ya fara aiki kan fitar da ka'idoji tun bayan sake kaddamar da ka'idoji na biyar na Hukumar Kirkirar Kimiyya da Fasaha. A matsayin abokin hulɗar dabarun Oryza Biotechnology, Fasahar Truking tana ba da mafita don samar da babban sikeli na samfurin Oryza Biotechnology na farko-samfurin "shinkafa hematopoietic". An kafa shi a cikin 2006, Oryza Biotechnology babbar masana'antar fasahar kere kere ce ta ƙasa wacce ta kware a cikin bincike da haɓaka samfuran fasahar magana da furotin recombinant Botanical. A watan Yulin 2025, Hukumar Abinci da Magunguna ta Jiha ta amince da ƙaddamar da Oryza Biotechnology, allurar farko na recombinant ɗan adam (shinkafa) magani a duniya (sunan kasuwanci: Aofumin), wanda ya nuna babban ci gaban fasaha a fagen samar da ƙwayoyin cuta na duniya kuma ana iya kiransa "mu'ujiza" a cikin masana'antar. Ofumin ya fi dacewa don maganin hanta cirrhosis da hypoalbuminemia (<30 g / l). Ana amfani da tsaban shinkafa azaman bioreactor don samar da recombinant ɗan adam albumin. Wannan ka'idar fasaha ta sami suna mai launi "shinkafa hematopoiesis." Tun daga 1981, an yi ƙoƙari na kasa da kasa don samar da albumin na ɗan adam a matsayin madadin hakar plasma, amma babu wani ci gaba na fasaha da aka samu.

Oryza Biotechnology Samfurin “shinkafa hematopoietic” na farko a duniya.
A shekara ta 2006, Yang Daichang ya kafa Oryza Biotechnology, ya yi bincike a kan fasahar amfani da iri shinkafa a matsayin bioreactor don samar da recombinant albumin dan adam, kuma ya jagoranci wani bincike da ci gaba tawagar don warware wannan matsala. Bayan tsawon shekaru na bincike mai ɗorewa, ƙungiyar ta yi nasarar dasa kwayar halittar albumin na ɗan adam zuwa shinkafa, wanda ya ba da damar ƙwayar shinkafa ta haɗar albumin na ɗan adam mai yawa. Ta hanyar keɓewa da tsarkakewa, tsaftar albumin ɗan adam recombinant ya kai fiye da 99.9999%. Nasarar Oryza Biotechnology ba wai kawai tana ba da ci gaba a fasahar "0 zuwa 1" tare da recombinant albumin ɗan adam ba, har ma ya cika gibi a manyan masana'antu na duniya da buɗe sabbin dama ga masu cutar hanta a duk duniya.

Fasahar Truking da rassanta sune samfuran farko na Oryza Biotechnology a duniya.Samar da manyan masana'antu mafita
Don saduwa da buƙatun kasuwa na recombinant albumin ɗan adam, Oryza Biotechnology ya haɓaka sabon aikin masana'antu don recombinant ɗan adam albumin, wanda aka gina a kusa da cikakken kewayon sarrafa kansa, bayanai da ra'ayoyin muhalli. Featuring chromatography, ultrafiltration, da dai sauransu Cikakken sarrafa kansa samar da kayan aiki samar da cikakken tsari iko daga samfurin tsaftacewa, CIP kayan aiki (in-line tsarkakewa) zuwa SIP (in-line haifuwa), minimizing kurakurai da kuma samuwar kasada lalacewa ta hanyar mutum sa baki, tabbatar da wani babban mataki na daidaito tsakanin batches da kuma kwanciya m tushe ga barga da kuma sarrafa samfurin ingancin. Da zarar aikin ya fara samarwa, za a iya ƙara ƙarfin samar da allurar albumin na Oryza Biotechnology na ɗan adam da ƙarin raka'a miliyan 12. A matsayin muhimmin abokin tarayya na Oryza Biotechnology, Fasahar Truking tana taimakawa wajen gina layin samar da allurar albumin na farko da aka samu a duniya. Wannan aikin tushe na masana'antu ya ƙunshi yanki na kadada 148.68 kuma jimillar ginin da aka tsara ya kai kusan murabba'in murabba'in 113,000. Aikin zai gina masana'antar sinadarai mai cikakken hankali, tare da haɗa cibiyar bincike da ci gaba, samar da matukin jirgi da layin samar da albumin na ɗan adam. A layin samar da Biotechnology na Oryza, Fasahar Truking tana ba da cikakken bayani na samarwa mai sarrafa kansa, daga cikawa da capping zuwa bushewar samfur, haifuwa da tsarin padding.
Ingenuity Truking, wani yanki na Chutian's biopharmaceuticals da sarkar masana'antar kimiyyar rayuwa, yana ba da cikakken saiti na jimlar rarrabuwar kai da mafita na tsarkakewa ga duka aikin. Maganin ya haɗa da ɗimbin saiti na tsarin shirye-shiryen ruwa na kan layi, ultrafiltration da sauran kayan aikin fasaha. A halin yanzu ana ci gaba da tara kayan aikin da kuma gyara kurakurai kuma ana sa ran isar da su a karshen shekara. Da zarar layin samarwa ya fara aiki, aikin samar da kayan aikin Oryza Biotechnology na recombinant albumin na ɗan adam zai ƙaru sosai, wanda zai ba shi damar ba da sabis ga yawancin marasa lafiya cikin inganci da aminci.

Fasahar Truking da rassanta sune samfuran farko na Oryza Biotechnology a duniya.Samar da manyan masana'antu mafita
Oryza Biotechnology ya samu nasarar samun ci gaba wajen samar da kayan aikin albumin na dan adam, inda ya samar da isasshen kariya ga lafiyar dan adam a duniya. A sa'i daya kuma, fasahar kere-kere da kamfanoninta irin su Truking Ingenuity, sun dukufa wajen warware kalubalen da ke tattare da yin fasahohin fasahohin harhada magunguna, kuma sun himmatu wajen yin hadin gwiwa tare da majagaba a fannin masana'antu, don sa kaimi ga bunkasuwar fasahar likitanci mai zaman kanta ta kasar Sin, da ba da gudummawa ga lafiyar duniya baki daya.




